Sort
11,323 grants matching “glioblastoma”
Targeting Glioma by Anti-MMPs-2 and -9 DNAzymes
$257,698University Of Tennessee Health Sci Ctr · R01 · FY2005 · CA
Comprehensive Identification of bivalent promoters in Brain Tumor Stem Cells
$257,619Gregory D Foltz · Swedish Medical Center, First Hill · R21 · FY2009 · CA
Modeling the effects of INK4 alpha ARF loss on gliomas
$257,447Sloan-Kettering Institute For Cancer Res · R01 · FY2001 · CA
Quantitative Image Informatics for Cancer Research (QIICR)
$257,375Ron Kikinis · Brigham And Women'S Hospital · U24 · FY2016 · CA
Metabolic Phenotyping with PET to Monitor and Predict Response to Kinase
$257,338Johannes Czernin · University Of California Los Angeles · P50 · FY2009 · CA
Clinical Trial Operations Core
$257,280Annick Desjardins · Duke University · P50 · FY2022 · CA
Recombinant Carcinoembryonic Antigen as a PET Reporter Gene
$257,253Anna M Wu · University Of California Los Angeles · P50 · FY2009 · CA
PRODUCTION OF ALTERNATIVE FGF RECEPTOR FORMS IN TUMORS
$257,250Gilbert J. Cote · University Of Tx Md Anderson Can Ctr · R01 · FY2006 · CA
Brain Tumor Imaging and Therapy Using Magnetic Nanoparticles
$257,160Wenbin Lin · Univ Of North Carolina Chapel Hill · U54 · FY2008 · CA
Clinical Studies Of Abnormal Host Defense
$257,105John I Gallin · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Project 1: Modeling the Interface between Non-invasive Imaging and Drug Distribution
$256,932Kristin R Swanson · Massachusetts Institute Of Technology · U54 · FY2019 · CA
Soluble EGFR as a Potential Serum Biomarker in Glioma
$256,878Joon H Uhm · Mayo Clinic Rochester · P50 · FY2007 · CA
RNA-based Immunotherapy Targeting Antigens Unique to Brain Tumor Stem Cells
$256,854John H Sampson · Duke University · R01 · FY2009 · CA
Modeling the effects of INK4 alpha ARF loss on gliomas
$256,725Sloan-Kettering Institute For Cancer Res · R01 · FY2003 · CA
Modeling the effects of INK4 alpha ARF loss on gliomas
$256,725Sloan-Kettering Institute For Cancer Res · R01 · FY2002 · CA
Evolution and targeting of the functional states of glioblastoma
$256,507Anna Lasorella · Columbia University Health Sciences · R01 · FY2022 · CA
Novel Mechanisms of Confined Migration of GBM Cells
$256,459Roland Horst Friedel · Icahn School Of Medicine At Mount Sinai · R21 · FY2025 · NS
De Novo Nucleotide Synthesis as a Mediator of Radiation Resistance and a Therapeutic Target in Glioblastoma
$256,400Daniel R Wahl · University Of Michigan At Ann Arbor · K08 · FY2019 · CA
Project 2: Integrative Genomics of Cancer Survival
$256,345Yen-Tsung Huang · Brown University · P20 · FY2018 · GM
CHARACTERIZING AGGRESSIVE GLIOMA COPY NUMBER SUBTYPES
$256,230Patrick J. Cimino · University Of Washington · K08 · FY2021 · CA
CHARACTERIZING AGGRESSIVE GLIOMA COPY NUMBER SUBTYPES
$256,230Patrick J. Cimino · University Of Washington · K08 · FY2020 · CA
North Carolina A&T University-Wake Forest Cancer Center partnership (1of 2)
$256,224Mary A Smith · North Carolina Agri & Tech St Univ · P20 · FY2011 · CA
DEUTERIUM METABOLIC IMAGING TO NONINVASIVELY MEASURE METABOLIC REPROGRAMMING IN GLIOBLASTOMA
$256,208Washington University, The · · FY2025 · Defense Health Agency
Leveraging doxorubicin immune-modulation, blood-brain barrier opening, and personalized medicine for effective immunotherapy in glioblastoma. A mechanistic approach and pharmacokinetic trial.
$256,156Adam M Sonabend · University Of California, San Francisco · U19 · FY2024 · CA
Neoantigen immunotherapy in brain tumors using anti-CD27 to deplete regulatory T cells selectively
$256,082John H Sampson · Duke University · P50 · FY2019 · CA